New valve procedure for high-risk patients
A new minimally invasive procedure to replace the heart valve of patients with aortic stenosis has been introduced at Imperial College Healthcare.
The new technique, called TAVI (transcatheter aortic valve implantation), will treat patients who are considered too high-risk for open-heart surgery.
The procedure, which is performed in a cardiology catheter laboratory rather than in an operating theatre, uses the Sapien transcatheter heart valve from Edwards Lifesciences.
Traditionally, aortic valves are replaced via open heart surgery, involving a major incision, putting the patient’s heart on bypass and a prolonged period of rehabilitation. Patients having the new procedure could have a shorter recovery period and potentially less time in hospital.
Dr Ghada Mikhail, cardiologist and programme lead for TAVI, said: “As this new technology develops we hope to be able to offer this procedure not only to older and higher-risk patients, but also to a wider group of lower-risk patients.”
Imperial College Healthcare Trust is the largest trust in the country and, in partnership with Imperial College London, is the UK’s first academic health science centre (AHSC). The AHSC was created to develop research discoveries into new and improved treatments to benefit patients in the trust.
For more information, visit www.edwards.com/eu.
PlasmaBlade gains CE approval for surgery PEAK Surgical Inc has received European CE Mark approval for the use of its PEAK Surgery System in general surgery.
The system includes the PULSAR Generator and the PEAK PlasmaBlade family of disposable, low-temperature surgical cutting and coagulation devices. The generator provides pulsed plasma radiofrequency energy to the PlasmaBlade to incise tissue and control bleeding.
“We are pleased that the European authorities have approved the use of the PEAK Surgery System. We continue to receive positive feedback from surgeons in the United States. They not only find the PlasmaBlade to be intuitive and easy to use, but also to precisely cut tissue and control bleeding without extensive collateral thermal damage to tissues,” said John Tighe, President and CEO of PEAK Surgical.
“We look forward to commercialising this innovative device in Europe, where we believe the PlasmaBlade could eventually be used in more than one million surgical procedures each year.”
PEAK Surgery System has been used in general surgery in the US since July 2008, and received further FDA clearance last December for cutting and coagulation of soft tissue during plastic and reconstructive, ENT, gynaecologic, orthopaedic, arthroscopic, spinal and neurological surgical procedures.
For more details, visit www.peaksurgical.com.
Keeping track of patients with 3M Diversified technology company 3M has launched a new RFID-enabled Patient Record Tracking Solution to help hospital staff locate patient records quickly and easily.
The new system places an RFID tag, linked to a 3M database, on each patient record. A network of strategically-placed tracking pads is created around the hospital. Each pad is connected to a computer, enabling hospital staff to locate any given record at the click of a button.
The launch comes at a time when the NHS’s patient record digitisation project faces scrutiny. Edward Leigh MP, Chairman of the Committee on Public Accounts, said recently on BBC Radio 4 that the Care Records System at the heart of the digitisation project was “way off the pace” and that even the revised completion date of 2014–15 for these systems “now looks doubtful”.
Paul Woolvine, Sales & Marketing Manager for 3M, said: “With fresh doubt about a 2015 deadline for the £12 billion patient record digitisation project, it is more important than ever that the NHS looks at technologies that can help deliver better, safer and faster care. We strongly believe that our RFID-based solution can allow hospitals within the NHS to do just this. The patient record becomes ‘intelligent’ and procedural compliance is made easy.”
To find out more, go to www.3m.com